For instance, because ghrelin stimulates appetite in rodents and humans, it was expected that ghrelin antagonists could exert beneficial effects against obesity; however, this strategy has failed (194, 195). Here, GHRL is linked to obesity due to melanocortin 4 receptor deficiency.